Your browser doesn't support javascript.
loading
Secondary solid cancer screening following hematopoietic cell transplantation.
Inamoto, Y; Shah, N N; Savani, B N; Shaw, B E; Abraham, A A; Ahmed, I A; Akpek, G; Atsuta, Y; Baker, K S; Basak, G W; Bitan, M; DeFilipp, Z; Gregory, T K; Greinix, H T; Hamadani, M; Hamilton, B K; Hayashi, R J; Jacobsohn, D A; Kamble, R T; Kasow, K A; Khera, N; Lazarus, H M; Malone, A K; Lupo-Stanghellini, M T; Margossian, S P; Muffly, L S; Norkin, M; Ramanathan, M; Salooja, N; Schoemans, H; Wingard, J R; Wirk, B; Wood, W A; Yong, A; Duncan, C N; Flowers, M E D; Majhail, N S.
Afiliación
  • Inamoto Y; Division of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
  • Shah NN; Pediatric Oncology Branch, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institute of Health (NIH), Bethesda, MD, USA.
  • Savani BN; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Shaw BE; Center for International Blood and Marrow Transplant Research (CIBMTR), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
  • Abraham AA; Division of Blood and Marrow Transplantation, Center for Cancer and Blood Disorders, Children's National Medical Center, Washington, DC, USA.
  • Ahmed IA; Department of Hematology Oncology and Bone Marrow Transplantation, The Children's Mercy Hospitals and Clinics, Kansas City, MO, USA.
  • Akpek G; Section of Hematology Oncology, Banner MD Anderson Cancer Center, Gilbert, AZ, USA.
  • Atsuta Y; 1] Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan [2] Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Baker KS; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Basak GW; Department of Hematology, Oncology and Internal Diseases, Medical University of Warsaw, Warsaw, Poland.
  • Bitan M; Department of Pediatric Hematology/Oncology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.
  • DeFilipp Z; Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA, USA.
  • Gregory TK; Colorado Blood Cancer Institute at Presbyterian/St Luke's Medical Center, Denver, CO, USA.
  • Greinix HT; Bone Marrow Transplantation Unit, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria.
  • Hamadani M; Center for International Blood and Marrow Transplant Research (CIBMTR), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
  • Hamilton BK; Blood and Marrow Transplant Program, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA.
  • Hayashi RJ; Division of Pediatric Hematology/Oncology, Department of Pediatrics, Washington University School of Medicine in St Louis, St Louis, MO, USA.
  • Jacobsohn DA; Division of Blood and Marrow Transplantation, Center for Cancer and Blood Disorders, Children's National Medical Center, Washington, DC, USA.
  • Kamble RT; Division of Hematology and Oncology, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX, USA.
  • Kasow KA; Division of Hematology-Oncology, Department of Pediatrics, University of North Carolina, Chapel Hill, NC, USA.
  • Khera N; Department of Hematology/Oncology, Mayo Clinic, Phoenix, AZ, USA.
  • Lazarus HM; Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, OH, USA.
  • Malone AK; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Lupo-Stanghellini MT; Unit of Hematology and Bone Marrow Transplantation, IRCCS San Raffaele Scientific Institute, Milano, Italy.
  • Margossian SP; Department of Pediatric Oncology, Boston Children's Hospital and Dana-Farber Cancer Institute, Boston, MA, USA.
  • Muffly LS; Division of Blood and Marrow Transplantation, Stanford University, Stanford, CA, USA.
  • Norkin M; Division of Hematology and Oncology, Department of Medicine, University of Florida, Gainesville, FL, USA.
  • Ramanathan M; Division of Hematology and Oncology, Department of Medicine, UMass Memorial Medical Center, Worchester, MA, USA.
  • Salooja N; Imperial College, London, UK.
  • Schoemans H; University Hospital of Leuven, Leuven, Belgium.
  • Wingard JR; Division of Hematology and Oncology, Department of Medicine, University of Florida, Gainesville, FL, USA.
  • Wirk B; Department of Internal Medicine, Stony Brook University Medical Center, Stony Brook, NY, USA.
  • Wood WA; Division of Hematology/Oncology, Department of Medicine, University of North Carolina, Chapel Hill, Chapel Hill, NC, USA.
  • Yong A; Royal Adelaide Hospital/SA Pathology and School of Medicine, University of Adelaide, Adelaide, Australia.
  • Duncan CN; Department of Pediatric Oncology, Boston Children's Hospital and Dana-Farber Cancer Institute, Boston, MA, USA.
  • Flowers ME; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Majhail NS; Blood and Marrow Transplant Program, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA.
Bone Marrow Transplant ; 50(8): 1013-23, 2015 Aug.
Article en En | MEDLINE | ID: mdl-25822223

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Tamizaje Masivo / Neoplasias Primarias Secundarias / Trasplante de Células Madre Hematopoyéticas Tipo de estudio: Diagnostic_studies / Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Female / Humans / Male Idioma: En Año: 2015 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Tamizaje Masivo / Neoplasias Primarias Secundarias / Trasplante de Células Madre Hematopoyéticas Tipo de estudio: Diagnostic_studies / Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Female / Humans / Male Idioma: En Año: 2015 Tipo del documento: Article